Related Experiment Video
Updated: May 18, 2026

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
Published on: March 14, 2011
Infectious complications following allogeneic stem cell transplantation: reduced-intensity vs. myeloablative
1Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.
Background:
In allogeneic stem cell transplantation (allo-SCT), reduced-intensity conditioning (RIC) is known for producing less regimen-related toxicity. However, whether or not RIC reduces the risk for infection and infection-related mortality (IRM) remains controversial.
Methods:
We retrospectively analyzed infectious episodes and IRMs after allo-SCTs by time period and by the intensity of the conditioning regimen (RIC [n = 81] vs. myeloablative conditioning, MAC [n = 150]).
Results:
The cumulative incidence of any kind of infection was lower in the RIC group through the entire period (72% vs. 87%; P = 0.007). The onset of infections was deferred in the RIC group as compared with the MAC group (P = 0.012). Bacteremia occurred less frequently in the RIC group through the entire period (5% vs. 14%; P = 0.044). However, the incidences of cytomegalovirus reactivation and disease, herpes zoster, virus-associated hemorrhagic cystitis, and invasive fungal infection were not different between the two groups. Furthermore, there was no difference in relapse-free survival and IRM between the two conditioning regimens.
Conclusion:
Careful monitoring and appropriate preventive/therapeutic strategies for infectious complications, comparable to those for allo-SCT recipients with MAC, should also be applied to those with RIC, especially after engraftment.
Insights
Reduced-intensity conditioning (RIC) in allogeneic stem cell transplantation (allo-SCT) lowers overall infection rates and delays infection onset. However, RIC does not reduce infection-related mortality compared to myeloablative conditioning (MAC).
Area of Science:
- Hematology
- Transplantation Immunology
- Infectious Diseases
Background:
- Reduced-intensity conditioning (RIC) in allogeneic stem cell transplantation (allo-SCT) is associated with lower toxicity.
- The impact of RIC on infection risk and infection-related mortality (IRM) after allo-SCT is not well-established.
Purpose of the Study:
- To compare the incidence and timing of infectious episodes and IRM between patients undergoing allo-SCT with RIC versus myeloablative conditioning (MAC).
Main Methods:
- Retrospective analysis of infectious episodes and IRM in 81 RIC and 150 MAC allo-SCT recipients.
- Comparison of infection rates, onset timing, and specific infection types between RIC and MAC groups.
Main Results:
- Patients in the RIC group had a lower cumulative incidence of any infection (72% vs. 87%, P = 0.007) and delayed infection onset (P = 0.012).
- Bacteremia was less frequent in the RIC group (5% vs. 14%, P = 0.044).
- No significant differences were observed in cytomegalovirus reactivation, herpes zoster, hemorrhagic cystitis, invasive fungal infections, relapse-free survival, or IRM between RIC and MAC groups.
Conclusions:
- While RIC reduces overall infection rates and delays onset, specific severe infections and IRM are comparable to MAC.
- Allo-SCT recipients with RIC require vigilant monitoring and infection management strategies similar to those for MAC recipients, particularly post-engraftment.
Related Concept Videos
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Cell-mediated Immune Responses
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Regulation of Hematopoietic Stem Cells
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...

